EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 320 filers reported holding EDITAS MEDICINE INC in Q3 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $98,000 | -62.5% | 8,040 | -63.5% | 0.01% | -50.0% |
| Q2 2022 | $261,000 | -37.7% | 22,027 | 0.0% | 0.01% | -29.4% |
| Q1 2022 | $419,000 | +160.2% | 22,027 | +263.4% | 0.02% | +183.3% |
| Q4 2021 | $161,000 | -53.7% | 6,062 | -28.5% | 0.01% | -45.5% |
| Q3 2021 | $348,000 | -36.5% | 8,479 | -12.4% | 0.01% | -15.4% |
| Q2 2021 | $548,000 | +35.0% | 9,678 | 0.0% | 0.01% | +30.0% |
| Q1 2021 | $406,000 | -50.4% | 9,678 | -17.0% | 0.01% | -41.2% |
| Q4 2020 | $818,000 | +132.4% | 11,663 | -6.9% | 0.02% | +112.5% |
| Q3 2020 | $352,000 | +15.4% | 12,534 | +21.4% | 0.01% | +14.3% |
| Q2 2020 | $305,000 | +36.8% | 10,324 | -8.2% | 0.01% | +40.0% |
| Q1 2020 | $223,000 | -44.0% | 11,246 | -16.4% | 0.01% | -44.4% |
| Q4 2019 | $398,000 | +30.1% | 13,448 | 0.0% | 0.01% | +28.6% |
| Q3 2019 | $306,000 | -16.8% | 13,448 | -9.7% | 0.01% | -12.5% |
| Q2 2019 | $368,000 | +7.6% | 14,890 | +55.9% | 0.01% | 0.0% |
| Q2 2018 | $342,000 | – | 9,551 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |